Presynaptic membrane polysialogangliosides

Presynaptic membrane polysialogangliosides are a class of sialic acid-containing glycosphingolipids, such as GD1a, GT1b, and GQ1b, that are highly enriched in the outer leaflet of neuronal membranes (Schengrund, 2015). They play a critical role in the nervous system by modulating cell signaling, stabilizing axon-myelin interactions, and serving as essential receptors for clostridial neurotoxins (Pirazzini et al., 2017). In a therapeutic context, these gangliosides act as the primary docking sites for Botulinum neurotoxins (BoNTs), where they facilitate high-affinity binding and subsequent endocytosis of the toxin into the nerve terminal (Rummel, 2016). This interaction is the foundational step for the clinical efficacy of drugs like OnabotulinumtoxinA, which are used to treat muscle spasticity, dystonia, and various cosmetic conditions (Dressler, 2012). Furthermore, these molecules are significant in pathology as the targets of autoantibodies in neurological disorders like Guillain-Barré syndrome and Miller Fisher syndrome (Willison et al., 2016). The presence of specific anti-ganglioside antibodies in patient serum serves as a key diagnostic biomarker for these autoimmune neuropathies.

Other names

PolysialogangliosidesComplex gangliosidesGD1aGT1bGQ1bGD1bSialoglycosphingolipids

These molecules function as high-affinity co-receptors in a dual-receptor mechanism, where they first capture and concentrate botulinum or tetanus neurotoxins on the presynaptic membrane surface, facilitating subsequent binding to protein receptors and toxin internalization (Pirazzini et al., 2017; Rummel, 2016).